154 related articles for article (PubMed ID: 8432290)
1. Hypertrophy or hyperplasia in cardiac muscle. Post-mortem human morphometric study.
Grajek S; Lesiak M; Pyda M; Zajac M; Paradowski S; Kaczmarek E
Eur Heart J; 1993 Jan; 14(1):40-7. PubMed ID: 8432290
[TBL] [Abstract][Full Text] [Related]
2. [Myocardial structure in various forms of hypertrophy. II. Myocyte hypertrophy or hyperplasia? Results of the study].
Grajek S; Paradowski S; Zajac M; Kaczmarek E
Kardiol Pol; 1990; 33(6):384-95. PubMed ID: 2150680
[TBL] [Abstract][Full Text] [Related]
3. [Hypertrophy or hyperplasia of myocytes in heart hypertrophy?].
Grajek S; Paradowski S; Zajac M; Kaczmarek E
Przegl Lek; 1992; 49(12):395-8. PubMed ID: 1341756
[TBL] [Abstract][Full Text] [Related]
4. Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure.
Olivetti G; Melissari M; Balbi T; Quaini F; Cigola E; Sonnenblick EH; Anversa P
Cardiovasc Res; 1994 Aug; 28(8):1199-208. PubMed ID: 7954623
[TBL] [Abstract][Full Text] [Related]
5. Constituents of the human ventricular myocardium: connective tissue hyperplasia accompanying muscular hypertrophy.
Moore GW; Hutchins GM; Bulkley BH; Tseng JS; Ki PF
Am Heart J; 1980 Nov; 100(5):610-6. PubMed ID: 6449858
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of end-stage failure in ischemic cardiomyopathy in humans.
Beltrami CA; Finato N; Rocco M; Feruglio GA; Puricelli C; Cigola E; Quaini F; Sonnenblick EH; Olivetti G; Anversa P
Circulation; 1994 Jan; 89(1):151-63. PubMed ID: 8281642
[TBL] [Abstract][Full Text] [Related]
7. [Morphologic findings during regression of heart hypertrophy].
Frenzel H
Z Kardiol; 1985; 74 Suppl 7():107-18. PubMed ID: 2936013
[TBL] [Abstract][Full Text] [Related]
8. Comparison of myocardial changes between pressure induced hypertrophy and normal growth in the rat heart.
van der Laarse A; Vliegen HW; van der Nat KH; Hollaar L; Egas JM; Swier GP; van den Broek AJ
Cardiovasc Res; 1989 Apr; 23(4):308-14. PubMed ID: 2531632
[TBL] [Abstract][Full Text] [Related]
9. The cellular basis of dilated cardiomyopathy in humans.
Beltrami CA; Finato N; Rocco M; Feruglio GA; Puricelli C; Cigola E; Sonnenblick EH; Olivetti G; Anversa P
J Mol Cell Cardiol; 1995 Jan; 27(1):291-305. PubMed ID: 7760353
[TBL] [Abstract][Full Text] [Related]
10. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans.
Rossi MA
J Hypertens; 1998 Jul; 16(7):1031-41. PubMed ID: 9794745
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the diameter and length of hypertrophic cardiomyocytes in the dilated left ventricle of cardiac surgical patients].
Egorova IF; Serov RA; Kuts EV; Mironenko VA
Arkh Patol; 2017; 79(6):14-21. PubMed ID: 29265073
[TBL] [Abstract][Full Text] [Related]
12. Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats.
Olivetti G; Ricci R; Anversa P
J Clin Invest; 1987 Dec; 80(6):1818-21. PubMed ID: 2960697
[TBL] [Abstract][Full Text] [Related]
13. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats.
Kajstura J; Zhang X; Reiss K; Szoke E; Li P; Lagrasta C; Cheng W; Darzynkiewicz Z; Olivetti G; Anversa P
Circ Res; 1994 Mar; 74(3):383-400. PubMed ID: 8118947
[TBL] [Abstract][Full Text] [Related]
14. [Left ventricle hypertrophy following myocardial infarction. Morphometric evaluation of the infarcted region and the free wall of the left ventricle].
Prech M; Grajek S; Lesiak M; Mularek-Kubzdela T; Marszałek A; Paradowski S; Cieśliński A
Pol Arch Med Wewn; 2004 Nov; 112(5):1289-96. PubMed ID: 15773510
[TBL] [Abstract][Full Text] [Related]
15. Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats.
Olivetti G; Quaini F; Lagrasta C; Ricci R; Tiberti G; Capasso JM; Anversa P
Am J Pathol; 1992 Jul; 141(1):227-39. PubMed ID: 1385927
[TBL] [Abstract][Full Text] [Related]
16. Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans.
Olivetti G; Melissari M; Balbi T; Quaini F; Sonnenblick EH; Anversa P
J Am Coll Cardiol; 1994 Jul; 24(1):140-9. PubMed ID: 8006257
[TBL] [Abstract][Full Text] [Related]
17. [Left ventricular remodelling and rebuilding of the infarcted area. Morphometric evaluation of the relationships between left ventricular mass, myocyte diameter, capillary density and fibrosis].
Prech M; Grajek S; Marszałek A; Filas V; Lesiak M; Oko-Sarnowska Z; Cieśliński A
Pol Arch Med Wewn; 2006 Oct; 116(4):930-7. PubMed ID: 18416294
[TBL] [Abstract][Full Text] [Related]
18. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development.
Li F; Wang X; Capasso JM; Gerdes AM
J Mol Cell Cardiol; 1996 Aug; 28(8):1737-46. PubMed ID: 8877783
[TBL] [Abstract][Full Text] [Related]
19. Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure.
Koda M; Takemura G; Kanoh M; Hayakawa K; Kawase Y; Maruyama R; Li Y; Minatoguchi S; Fujiwara T; Fujiwara H
J Pathol; 2003 Feb; 199(2):229-36. PubMed ID: 12533836
[TBL] [Abstract][Full Text] [Related]
20. Evidence of myocyte hyperplasia in hypertrophic cardiomyopathy and other disorders with myocardial hypertrophy?
Ferrans VJ; Rodríguez ER
Z Kardiol; 1987; 76 Suppl 3():20-5. PubMed ID: 2963448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
